Evidence map›Paper›PMID 25419280›Full record

Observational studyThe Pan African medical journal2014

[Evolution of chronic myeloid leukemia on nilotinib after failure of imatinib].

Salifo Sawadogo, Francis Michel Hien, Macaire Sampawendé Ouédraogo, Youssouf Joseph Drabo

Abstract readCase ReportsObservational Study
In one paragraph

Observational study in The Pan African medical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Salifo SawadogoLaboratoire d'hématologie et d'immunologie du Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso 01 Burkina Faso.
Francis Michel HienService de médecine interne, Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso Burkina Faso.
Macaire Sampawendé OuédraogoService de médecine interne, Centre hospitalier universitaire Sourô Sanou, 01 BP 676 Bobo-Dioulasso Burkina Faso.
Youssouf Joseph DraboService de médecine interne Centre hospitalier universitaire Yalgado Ouédraogo, 03 BP 7022 Ouagadougou 03 Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAntineoplastic AgentsBenzamidesDisease ProgressionFemaleHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedPiperazinesPyrimidinesTreatment FailureYoung AdultAntineoplastic AgentsBenzamidesImatinib MesylatenilotinibPiperazinesPyrimidineschronic myeloid leukemiadrug resistanceImatinibintoleranceNilotinib

Identifiers

PMID25419280
PMCPMC4236772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.